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Abstract: The purpose of this project was to investigate
the angiogenic mechanism of bioactive borate glass for
soft tissue repair in a ‘hairless’ SKH1 mouse model. Sub-
cutaneous microvascular responses to bioactive glass mi-
crofibers (45S5, 13-93B3, and 13-93B3Cu) and bioactive
glass beads (13-93, 13-93B3, and 13-93B3Cu) were assessed
via: noninvasive imaging of skin microvasculature; his-
tomorphometry of microvascular densities; and quanti-
tative PCR measurements of mRNA expression of VEGF
andFGF-2 cytokines. Live imaging via dorsal skinwindows
showed the formation at twoweeks of a halo-like structure
infused with microvessels surrounding implanted borate-
based 13-93B3 and 13-93B3Cu glass beads, a response not
observed with silicate-based 13-93 glass beads. Quantita-
tive histomorphometry of tissues implanted with plugs of
45S5, 13-93B3, and 13-93B3Cu glass microfibers revealed
microvascular densities that were 1.6-, 2.3-, and 2.7-times
higher, respectively, than the sham control valueswhereas
13-93, 13-93B3, and 13-93B3Cu glass beads caused the mi-
crovascular density to increase 1.3-, 1.6-, and 2.5-fold,
respectively, relative to sham controls. Quantitative PCR
measurements indicate a marginally significant increased
expression of VEGF mRNA in tissues with 13-93B3Cu glass
beads, an outcome that supported the hypothesis that
copper-doped borate glass could promote VEGF expres-
sion followed by angiogenesis for enhanced wound heal-
ing.
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1 Introduction
Each year approximately 6.5 million people in the United
States receive treatment for non-healing chronic skin
wounds, a significant health care challenge that costs an
estimated $25 billion dollars annually [2]. Chronic skin
wounds, wounds that do not heal within three months,
consist of three primary types: venous ulcers, diabetic ul-
cers, and pressure ulcers [3]. Wounds of these types fre-
quently become infected and gangrenous, often resulting
in amputation and increased mortality [4]. Although the
cause of impaired healing of chronic skin wounds remains
unknown, there is compelling indirect evidence that neo-
vascularization and angiogenesis have central roles in the
healing of soft tissue wounds. This link has been estab-
lished by numerous clinical observations of insufficient
angiogenesis associated with non-healing chronic skin
wounds [5–12]. As an example, non-healing diabetic foot
ulcers appear to be an outcome of the diminished periph-
eral blood flow that is common to diabetic patients [13].
The finding that specific angiogenic cytokines are
often deficient in patients with chronic wounds has
prompted tests of various pro-angiogenic growth factors in
experimental treatments of chronic wounds [14]. As an ex-
ample, the pro-angiogenic growth factor platelet derived
growth factor (PDGF) is the active component in the topi-
cal gel Becaplerminused in trial clinical treatment of lower
extremity ulcers [15]. Other experimental treatments with
promising results include the use of vascular endothelial
growth factor A (VEGFA) and fibroblast growth factor B
(bFGF or FGF2), both of which are known to promote an-
giogenesis [16, 17]. At present, PDGF is the only growth fac-
tor approved by the FDA for treating non-healing chronic
wounds in humans [18].
A simpler and less expensive method for cytokine-
induced angiogenesis might involve incorporation of pro-
angiogenic ions in wound treatment materials. Ions such
as copper, cobalt, boron, and zinc have been shown to
* A preliminary report of the project was presented by Delbert E. Day
at Glass & Optical Materials Division and Deutsche Glastechnische
Gesellschaft Joint Annual Meeting, May 17-21, 2015, Miami, Florida,
USA [1].
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Table 1: Composition of bioactive glasses used for subdermal implantations (composition values listed as wt.%).
Glass SiO2 B2O3 Na2O CaO MgO K2O P2O5 CuO
45S5 45.00 0 24.50 24.50 0 0 6.00 0
13-93 53.00 0 6.00 20.00 5.00 12.00 4.00 0
13-93B3 0 53.00 6.00 20.00 5.00 12.00 4.00 0
13-93B3Cu 0 52.79 5.98 19.92 4.98 11.95 3.98 0.40
have positive effects on angiogenesis [19, 20]. Dissolvable
materials containing one or more of these pro-angiogenic
ions could be effective vehicles for localized delivery of an-
giogenic ions. Dissolution products released from boron-
doped 45S5 bioactive glass were recently reported to pro-
mote in vitro proliferation of endothelial cells [21] and in
vivo angiogenesis [22]. Borate-based bioactive glass was
recently tested as a delivery device for angiogenic ions
in soft tissue repair [23]. Bioactive glass scaffolds doped
with copper and other elements were subcutaneously im-
planted into laboratory rats and left for six weeks. Anal-
ysis of tissues implanted with scaffolds prepared from a
borate-based glass designated 13-93B3 and 13-93B3 with
0.4% CuO showed a higher density of microvasculature
than thosewith silica-based glass fiber scaffolds (although
no sham control tissues were included for baseline com-
parison) [23]. Based on the promising outcome of the ro-
dent study an initial clinical evaluation of the use of bo-
rate glass microfibers in wound healing was performed
by the wound care unit at Phelps County Regional Med-
ical Center (PCRMC). That study included 12 volunteers
with chronic venous stasis wounds that were treated topi-
cally with repeated applications of microfibrous dressings
of 13-93B3 or 13-93B3Cu glass microfibers. Both of the two
glasses accelerated the healing of previously unresponsive
dermal wounds with complete healing of chronic wounds
in 8 of the 12 patients in the clinical study. Empirical ob-
servations by the hospital staff showed that the 13-93B3
glass appeared to promote re-epithelialization while 13-
93B3Cu microfibers appeared to promote granulation in
wound healing [24]. A follow-up quantitative evaluation
of the response of soft tissue to implants of borate-based
microfibrous glass was recently conducted in a rodent
model [25]. Compressed mats of microfibrous glass were
subcutaneously implanted in Sprague Dawley rats and
histologically evaluated at two, three, and four week in-
tervals. Histomorphometric results indicated that borate-
based microfibrous glass doped with copper did promote
angiogenesis.
This study was undertaken via three approaches to
investigate the underlying mechanism of the angiogenic
effect of bioactive borate glass using the SKH1 ‘hairless’
mouse as a model system. The first approach, pursued at
the macroscopic level, involved real-time imaging of lo-
calized tissue responses to bioactive glass in dorsal skin
fold preparations. The second approach involved histo-
morphometric assessment of the microvascular response
to bioactive borate glass in excised subdermal tissues.
The third and final approach involved measurement of
cytokine expression in subdermal tissues implanted with
copper-doped borate glass. The results supported our ba-
sic hypothesis that 13-93B3Cu bioactive glass stimulates
expression of the cytokine VEGF resulting in angiogenesis
in the treated tissue.
2 Materials And Methods
2.1 Bioactive glass
Bioactive glass materials used in this study (provided by
MO-SCI Inc, Rolla, MO) included two types of silica-based
glasses, 45S5 glass and 13-93 glass, plus two borate-based
glasseswith thedesignations 13-93B3and 13-93B3Cu. Com-
positions of these four glasses are provided in Table 1.
The materials were used in two physical forms for im-
plantation: plugs of compressed glass microfibers; and
fused glass beads. Batched glass microfibers (10±0.5 mg)
were compressed in a specially constructed teflon mold to
form 2 mm diameter porous plugs (example shown in Fig-
ure 1A). Additional 10 mg±0.5 mg batches of the glass mi-
crofibers were placed in a graphite mold and each batch
fused with a butane torch to create a smooth spherical
bead (Figure 1B). The compressed glass microfiber plugs
and glass beads were sterilized by dry heating overnight
at 200∘C prior to implantation.
2.2 Dorsal skin window frame
Special frames for viewing microvessels were fabri-
cated from 0.45 mm thick aluminum stock using two
25 mm × 15 mm rectangular pieces to form one frame. Two
8 mm diameter windows were bored in each frame, the
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Figure 1: Two physical forms of the bioactive glass samples im-
planted in mice. (A) Compressed 2 mm diameter plugs of glass
microfibers (side view); (B) fused 2 mm diameter glass bead. Both
samples shown here are 13-93B3Cu glass (hence blue color). Scale
bar represents 1.0 mm.
Figure 2: Installed skin window frame on SKH1 mouse immediately
after surgical implantation of fused glass beads (raised area in each
window).
edges were smoothed, and five 1.5 mm holes added along
the perimeter for suturing the frame to the dorsum of the
mouse.
2.3 Animals
All experiments were performed with female 5 to 7 week
old SKH1 mice (24±4 g). This murine strain was chosen
because of its hairless trait, a feature that facilitates the
trans-illuminated viewingof skinmicrovessels. NIHguide-
lines for the care and use of laboratory animals (NIH Pub-
lication #85-23 Rev. 1985) were followed.
2.4 Surgical procedures
Each of two replicate experiments for real-time microvas-
cular imaging and histomorphometric assessment in-
cluded four treatment groups with three animals per
group. Test animals were anesthetized by intraperitoneal
injection of a ketamine/xylazine/acepromazine mixture
and the dorsal surface disinfected with Betadine surgical
scrub. The prepped animal was placed on a temperature-
controlled stainless steel surgical platform and a fold of
dorsal skin was lifted and centered. Two 3 mm incisions
were made along the mid-sagital axis in the dorsal skin
fold approximately 16 mm apart and a subdermal pocket
formed at each incision. After pipetting 3 µl of phosphate
buffered saline (PBS) into the incision to act as lubricant, a
sterile 1.5mmdiameter stainless steel rodwas used to gen-
tly push either a glass plug or a glass bead approximately
8 mm into the subdermal pocket and the incision then
closed using aminimal amount of cyanoacrylate adhesive.
Following implantation of the bioactive glass samples, a
pre-sterilized framewas positioned such that the implants
were approximately in the middle of each of the two win-
dows as shown in Figure 2. The two sides of the dorsal
skin window frame were sutured together with Ethicon 4-
0 black nylonmonofilament followed by subcutaneous in-
jection of Ketofen analgesia for post-surgical painmanage-
ment. There were no losses due to infection. A final exper-
iment performed for measurement of cytokine expression
included four treatment groups with three animals per
group. A single 3 mm incision was created along the dor-
sal midline and a blunt probe was used to form two con-
tralateral subdermal pockets. Two bioactive glass beads
were separately placed in the incision, gently guided into a
subdermal pocket, and the incision closed with a minimal
amount of cyanoacrylate adhesive.
2.5 Dorsal skin window imaging
To begin the imaging, an alert animal was secured in a
tubular restraint device and then placed on a plexiglass
viewing platform with the animal positioned on its side.
A fiber optic light source mounted below the platform was
adjusted to project light through the skin enclosed in the
window frame. The 10x macrozoom lens of a digital cam-
era mounted on a boom stand above the platform was ad-
justed to bring the trans-illuminated skin fold into focus
and digital images of the tissue were collected.
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2.6 Tissue collection and processing for
histology
At three weeks post-implantation, animals were eutha-
nized by CO2 inhalation. Each implantation site (bead or
plug)was excisedwith an 8mmbiopsy punch (Miltex) and
immediately placed in 10% neutral buffered formalin for
four days. Fixed tissue samples were rinsed twice in PBS
two times, dehydrated in a vacuum infiltration tissue pro-
cessor (TissueTek 2000), and embedded in paraffin. Tissue
blocks were sectioned at 5 µm and mounted on positively
charged microscope slides.
2.7 Staining and Histomorphometry
Mounted sections of subdermis were stained using Peri-
odicAcid Schiff (PAS) solution followedbya 1% light green
counterstain. This sequence caused the endothelial basal
lamina to stain dark blue by the PAS solution while ery-
throcytes were stained green by the 1% light green coun-
terstain thereby facilitating visualization of the microvas-
culature [26]. Stained tissue sections were examined un-
der an Olympus BX53 microscope fitted with an Olympus
DP70 digital camera. Using the 4× objective, the entire tis-
sue section was scanned, digitally photographed, and the
4×photos ‘photomerged’ to forma single composite image.
Each composite image was then overlaid with a numbered
grid that was sized such that each individual box of the
grid corresponded to the area of one 20× field (as shown
in Figure 3). Continuing with the 4× objective, the boxes of
Figure 3: Steps of randomly selecting 20× fields for quantification.
A grid overlay scaled such that each box represents a 20× field was
placed on a composite image of PAS-stained tissue followed by ran-
domized selection of four of the qualified fields for quantification.
the grid were examined to identify ‘qualified’ fields, which
were those in which subdermis comprised 50% or more of
the area within the box. Using the random number gen-
erator function of Microsoft Excelr, four of the ‘qualified’
fields were randomly selected for detailed histological ex-
amination under the 20× objective to identify and encir-
cle microvessels. ImageJ software was then used for his-
tomorphometric evaluation of microvessel density via the





Total Area − VoidArea
)︂
× 100
2.8 Extraction of total RNA
Immediately following euthanasia, whole skin at the im-
plant site was excised with an 8 mm biopsy punch and
snap frozen in liquid nitrogen. Each implanted treatment
bead or plug was carefully removed and the frozen tis-
sue then pulverized under liquid nitrogen using a pre-
chilled mortar and pestle. TRIzolr reagent was used to
isolate total RNA via a modified procedure of Chomczyn-
ski & Sacchi [27, 28]. The gel-like RNA pellet was washed
twice in RNase-free ethanol, partially dehydrated, and
suspended in 40 µl diethylpyrocarbonate (DEPC) treated
water. The quantity of total RNA recovered was deter-
mined from 260 nm and 280 nm absorbance measure-
ments with a Nanodrop 3000 spectrophotometer. To as-
sess RNA quality, an aliquot of total RNA (1 µg) was run
on a 1% agarose/formaldehyde denaturing gel and the gel
then stained with SYBR-Gold nucleic acid stain for visual-
izationof the sharpness of 18S and 28Sbandswith absence
of smearing.
2.9 Analysis of gene expression by
quantitative PCR
Analysis of gene expression by quantitative PCR (qPCR)
was performed on a fee basis by the Mouse Biology Pro-
gram at the University of California-Davis The one, two,
and three week RNA samples from sham control and the
13-93B3Cu treated tissues were converted to complemen-
tary DNA (cDNA) and custom constructed oligonucleotide
probes (TaqManr probes) specific for the VEGF and FGF-2
genes were synthesized plus a probe for the GAPDH gene
which was used as an endogenous control. As product
cDNAwas amplified during thermal cycling, the TaqManr
probe for each cytokine was degraded and a fluorescent
signal eventually detected by the fluorescence sensor of
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Figure 4: Skin window imaging of tissue responses to microfibrous
plugs. Photos show nine day progression of responses to 13-93B3
and 13-93B3Cu microfibrous plugs compared to a sham implant
control.
Figure 5: Skin window imaging of tissue responses to glass beads.
Photos show three week progression of responses to 13-93, 13-
93B3, and 13-93B3Cu glass beads compared to a sham implant
control.
the instrument. The thermal cycle at which the concen-
tration of amplified product cDNA reached the detection
threshold (designated Ct, the threshold cycle) was used as
ameasurement endpoint of the assay [29]. The levels of ex-
pression of target geneswere normalized to theGAPDHen-
dogenous control by subtracting the control Ct value from
the target gene Ct to obtain ∆Ct values [30]. Comparisons
between treatment groups of relative expression of a tar-
get gene was determined by delta-delta Ct calculation [30]
where 2^(−∆∆Ct) represents the relative fold difference be-
tween target gene expression in a treated tissue sample
compared to the same target gene in a sham control sam-
ple.
2.10 Statistical analysis
Data sets are presented as means ± standard error of the
mean. Evaluation of treatment groups from experiments
was done by one way analysis of variance (ANOVA) fol-
lowed by the Tukey post-hoc test to identify significant dif-
ferences between treatment groups. Differences between
groupswere considered significantwith p-values less than
0.05 (p < 0.05) and marginally significant with p-values
less than 0.10 (p < 0.10).
3 Results
3.1 Imaging of localized tissue response to
bioactive glass implants
Thematerials initially used for live imagingof localized tis-
sue responses were compressed plugs of glassmicrofibers.
Successful imaging of implants for two or more weeks was
possible with fewer than 30% of the microfibrous glass
plugs. Examples of responses that were successfully im-
aged in those tissues are presented in Figure 4. The im-
ages in this figure show a nine day progression of tissue
responses to implanted plugs of borate based 13-93B3 and
13-93B3Cu microfibers compared to a sham implant con-
trol. Day zero pictures were taken within 30 minutes af-
ter implantation of the test materials. Minor edema was
observed in the tissue surrounding the 13-93B3Cu plug al-
though the edema subsided prior to the subsequent day
7 picture. The day 7 photo shows a halo response begin-
ning to develop around the 13-93B3Cu plug extending ap-
proximately 1 mm beyond the periphery of the implant. At
day 9, the 13-93B3Cu plug was encircled by a prominent
halo response that was approximately 5 mm in diameter
andqualitativelymorepronounced thanat day 7.As shown
in the figure, a minor halo response was visible encircling
the 13-93B3 plug at day 9. The tissue at the sham implant
control site remained unchanged during the course of the
nine day observation period with no visible halo develop-
ment. In contrast to the samples shown here, many of the
other microfibrous plug implants were within a few days
surrounded by erythema and mild edema, early phase in-
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Table 2: Qualitative evaluation of soft tissue response to beads implanted in dorsal skin.
Implant
interval




Fraction with halo Halo
density*
1 wk none (Sham) (5) (4) 0/4 0
13-93 5 5 0/5 0
13-93B3 5 5 0/5 0
13-93B3Cu 5 4 1/4 +
2 wk none (Sham) (5) (4) 0/4 0
13-93 5 5 0/5 0
13-93B3 5 5 3/5 ++
13-93B3Cu 5 4 3/4 ++
3 wk none (Sham) (5) (3) 0/3 0
13-93 5 5 1/5 +
13-93B3 5 5 3/5 ++
13-93B3Cu 5 3 2/3 ++/+ + +
* Key to qualitative assessment of halo density:
No halo observed
Minor redness surrounding glass bead
Complete halo surrounding glass bead
Intense halo surrounding bead
flammatory responses that obscured direct tissue imaging.
To reduce the inflammatory response artifact, spherical
beads of fused glass were adopted for subsequent implan-
tations. The rationale for switching to spherical beads was
the premise that the smooth surface of the beads would be
less irritating than compressedmicrofibers,manyofwhich
have exposed ends that could cause tissue irritation.
Representative live macroscopic images of localized
tissue responses to bioactive glass beads implanted in
dorsal skin window preparations and subsequently pho-
tographed at one, two and three weeks after implantation
are shown in Figure 5. The week zero skin window pho-
tos show minor inflammation that formed quickly around
the 13-93 and 13-93B3 beads. This minor inflammation ap-
peared to subside before the follow-up week one photos
were taken. One week post implantation there was little or
no observable responsewith any of the implanted beads or
sham control implantations except for minor redness sur-
rounding one of the implanted 13-93B3Cu beads and one
13-93B3 bead. Tissue response at week 2 shows a halo-like
body surrounding a 13-93B3 and 13-93B3Cu bead. The ha-
los around the beads at week 2 extended approximately
1 mm beyond the edge of the bead, a finding also ob-
served with the other borate beads that were implanted.
Another interestingmorphological feature observed in the
week 2 images is an increasing prominence of the large
vessels near the 13-93B3 bead. There were no discernable
changes in appearance of the sham control tissues dur-
ing the three week observation period. There was a dis-
cernable difference between the borate based 13-93B3 and
13-93B3Cu beads and the silicate based 13-93 glass beads
at week 3. The borate-based 13-93B3 bead had a distinct
and localized halo response around the implant. In con-
trast, the silicate-based 13-93 glass beads produced little
or no discernable halo response. Qualitative evaluations
of soft tissue response to beads are presented in Table 2.
As indicated in the table, a distinct halo-like body was
observed around only one of the five 13-93 silicate glass
beads at week 3. In contrast, distinct halos were observed
at week 3 around three of the five implanted 13-93B3 beads
and two of the three remaining 13-93B3Cu beads. The ha-
los surrounding the borate-based 13-93B3 and 13-93B3Cu
beadshadanouter diameter of approximately 3–4mm,be-
came prominent at week two, and remained distinct until
the animals were sacrificed at week three. Overall, the out-
come of the live imaging was the finding of essentially no
new vessels nor increased microvascular density visible
in tissue surrounding the 13-93 glass beads while tissues
implanted with the borate-based 13-93B3 and 13-93B3Cu
beads showed consistent halo formation around the im-
planted bead.
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Figure 6: Representative 3 week photo images of tissue response to
beads implanted subdermally without skin window frames. Tissues
were photographed from the subdermal side rather than by indirect
viewing through the skin from the epidermal side. The glass beads
implanted were: (A) 13-93; (B) 13-93B3; and (C) 13-93B3Cu. Scale
bar represents 1 mm.
Figure 7: Representative 20× photo images of PAS-stained sections
of tissue recovered after 3 weeks from subcutaneous sites of im-
plantation of bioactive glass microfibers. The types of microfibers
implanted were: (A) none (sham control); (B) 45S5 (C) 13-93B3; and
(D) 13-93B3Cu. Arrows point to some of the microvessels seen in the
tissues. Scale bar represents 50 µm.
A follow-up ancillary experiment was conducted to
further characterize the halo structures. The follow-up in-
cluded a separate group of 10 SKH1 mice that received
subdermal implantations of 13-93, 13-93B3, and 13-93B3Cu
fused beads without the use of the skin window frames.
The objective was direct imaging of subdermal microvas-
cular responsesbyphotoimaging the subdermis of necrop-
sied skin rather than by indirect viewing of subdermal mi-
crovascular responses from the epidermal side of intact
live skin enclosed within the dorsal skin window prepa-
rations. Three weeks after implantation, the animals were
euthanized and the skin reflected for macroscopic photo
imaging of the subdermal soft tissue. Three of the four
sham implantation sites were no longer detectable when
the subdermal surface of the necropsied skin was exam-
ined whereas at the one sham site that was still some-
what discernable there was only a very small (< 1 mm
diameter), slightly reddish body. The outcome with the
beads, as shown by the representative images in Figure 6,
was the finding of a reddish, halo-like structure surround-
ing each of the four implanted 13-93B3Cu beads and each
of the four implanted 13-93B3 beads but no similar halo-
like structure at any of the four sites with 13-93 beads. As
shown, thehalo-like structures surrounding the 13-93B3Cu
beads were more intense than the halos surrounding the
13-93B3 beads. It was noticed that the halo around the
13-93B3Cu beads included well delineated microvessels.
Furthermore, the halo structures around 13-93B3Cu beads
were about 4 mm in diameter, similar to the size of the
halo-like structures observed in the live dorsal skin win-
dowpreparations. The physical appearance of the implant
was also observed. At three weeks post implantation the
glass beads were intact, appeared to be the same diameter
aswhen initially implanted, andhadnonoticeable reacted
layer on their surface.
3.2 Sample recovery and histological
evaluation of soft tissue response
At conclusion of the three week implantation, discs of
whole skin were excised from the dorsal skin fold prepara-
tions and the implants quickly examined. The microfiber
plugs appeared approximately the same size at three
weeks post-implantation but were covered with a thin
white reacted layer. In addition, the plugswere soft, moist,
and crumbled upon removal. The glass beads appeared
the same diameter as when implanted, remained intact
upon removal, and had no discernable reactive layer on
their surface. After processing and staining, the entire area
of each tissue section was initially scanned under a 4× ob-
jective and composite 4× images prepared. Many of these
tissue sections had a central void area that corresponded
to the site of implantation of the test glass sample.
The four panels of Figure 7 show representative 20×
images of PAS-stained sections of subdermal tissues re-
moved three weeks after implantation of glass microfiber
plugs. Figure 7A, an example of subdermis observed in
necropsied tissues from sham control implant sites, shows
adipose and areolar tissues with a lowmicrovascular den-
sity. The image in Figure 7B is a representative exam-
ple of tissue implanted with silicate-based 45S5 glass mi-
crofibers. The section shown here has a tissue composi-
tion similar to that of the sham control sample plus a sim-
ilar microvessel density. Moderate amounts of fibrous tis-
sue were observed in the tissue samples from the sites of
implantation of 13-93B3 and 13-93B3Cu glass microfibers
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Figure 8: Representative 20× photo images of PAS-stained sections
of tissue recovered after 3 weeks from subcutaneous sites of im-
plantation of fused bioactive glass beads. The types of glass beads
implanted were: (A) none (sham control); (B) 1393 glass; (C) 13-93B3
glass; and (D) 13-93B3Cu. Arrows point to some of the microvessels
seen in the tissues. Scale bar represents 50 µm.
Figure 9: Comparison of microvessel densities three weeks post im-
plantation in response to fused bioactive glass beads and microfi-
brous plugs. Values are means ± SEM for five replicates with each
material. Asterisks (*) identify group means significantly different
from sham control at p < 0.05.
(shown in Figures 7C and 7D, respectively. The tissues from
implants sites with the 13-93B3Cu glass qualitatively ap-
peared to contain thehighest density ofmicrovessels of the
four treatment groups.
The four panels of Figure 8 show representative 20×
images of PAS-stained sections of subdermal tissues in
skin samples removed three weeks after implantation of
fused glass beads. The sham control sample in Figure 8A,
which is representative of skin samples from other sham
implant sites, shows adipose and areolar tissues with a
low microvascular density. The image in Figure 8B, a rep-
resentative example of skin tissue samples from sites with
the silicate 13-93 glass bead, shows tissue with amicrovas-
cular density similar to that of the sham control tissue.
Somewhat higher amounts of fibrous tissuewere observed
in tissue sections from the 13-93B3 and 13-93B3Cu im-
plantation sites (Figures 8C and 8D, respectively), a find-
ing seen in other tissue samples with the borate glass
beads. The microvasculature density appeared qualita-
tively higher in tissue with the borate-based 13-93B3 bead
(Figure 8C) and higher yet in tissue with the 13-93B3 Cu
bead (Figure 8D). Replicate tissue samples from the other
sites of implantation of 13-93B3Cu glass beads also ap-
peared qualitatively to have the highest density of mi-
crovessels. Many of the small microvessels visible in Fig-
ure 8D appear approximately the same diameter as an ery-
throcyte indicating that they are capillaries. The histolog-
ical evaluation revealed that the replicate tissue samples
recovered from the other sites of implantation of 13-93B3Cu
glass beads also appeared qualitatively to have the highest
density of microvessels.
3.3 Quantitative histomorphometry
A comparison of the microvessel density in soft tissue at
the sites of implantation of bioactive glass beads and glass
microfiber plugs is presented graphically in the bar chart
of Figure 9. The total vessel areas observed in the two
groups of sham control tissues were both calculated to be
2.6% of the total observed tissue area. Implantation of the
fused glass beads and glass microfiber plugs resulted in
the same overall trend for the tissue microvessel densi-
ties which were observed to be: lowest in the sham con-
trol tissues; slightly higher in tissues with silicate-based
13-93 or 45S5 glass; higher yet in tissues with 13-93B3 glass
beads and glass microfiber plugs; followed by the high-
est microvessel densities in tissues implanted with 13-
93B3Cu glass beads and glassmicrofiber plugs. The tissues
implanted with the 13-93, 13-93B3, and 13-93B3Cu glass
beads showed 33%, 58%, and 145% higher microvessel
density values relative to the three-week sham control tis-
sues, respectively. In a similarmanner, the tissues contain-
ing 45S5, 13-93B3, and 13-93B3Cu glass microfiber plugs
were found to have microvessel densities that were 56%,
124%, and 171%higher, respectively, compared to the three
week sham control tissues. Results of the ANOVA test re-
vealed the differences between the mean values of the
various groups were greater than would be expected by
chance and significant at the p < 0.05 level. The Tukey
post-hoc test indicated that the higher microvessel den-
sities of soft tissues with 13-93B3Cu glass beads or glass
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Figure 10: Agarose gel banding patterns of total RNA extract from a
sham control tissue compared with a ladder standard. Bright bands
in gel lane with the sample extract denote positions of 28S and 18S
ribosomal RNA.
microfiber plugs compared to the microvessel densities of
the sham control tissues was statistically significant at the
p < 0.05 level. The higher microvessel densities of tissues
implanted with 13-93B3 glass beads and 13-93B3 glass mi-
crofiber plugs compared to those in the sham control tis-
sues were found to be marginally significant at the p <
0.10 level. In contrast, themicrovessel densities of tissues
with silicate-based 45S5 and 13-93 glass beads and glass
microfiber plugs were not found to be statistically differ-
ent from those of the sham control tissues.
3.4 Analyses of total RNA extracts
The yields of total RNA extracted from the frozen skin sam-
ples ranged from 120 ng/µl to 276 ng/µl for aliquots sus-
pended in DEPC-treated water. The average A260/280 ra-
tios measured for the extracts of total RNA from the frozen
skin samples ranged from 1.82 to 1.88, values consistent
with good quality RNA [31]. A representative example of
Table 3: Quantitative PCR measurements of cytokine gene expres-
sion in skin tissues with sham or borate bead implants. The ∆Ct
values represent differences between target gene and endoge-
nous control gene expression; each ∆Ct value is a mean ± SEM for
three replicate tissue samples. The 2^(−∆∆Ct) values represent fold
















13-93B3Cu 1 9.3±0.3 0.5
13-93B3Cu 2 8.5±0.3 0.8




13-93B3Cu 1 5.2±0.2 0.8
13-93B3Cu 2 4.7±0.1 1.1
13-93B3Cu 3 4.0±0.3* 1.8
* Group mean marginally different from sham control
at p < 0.10.
the typical banding pattern seen after electrophoresis of
the total RNA samples on 1% agarose/formaldehyde dena-
turing gel followed by SYBR-Gold staining is shown in Fig-
ure 10. Loaded in one lane of the gel was 1 µg of total RNA
from a sham control sample and in the adjacent lane an
aliquot of a 500–9,000 base oligonucleotide ladder stan-
dard. The sample lane shows two intense bands at approx-
imately 5 kb and 1.9 kb which correspond to 28S rRNA and
18S rRNA, respectively. Another important point was the
near absence of smearing in the lane loaded with the sam-
ple extract RNA. A similar pattern of sharp 18S and 28S
bands with nearly complete absence of smearing was seen
in the gels run with all of the other preparations of total
RNAextracted from frozen skin samples, findings that con-
firm the integrity of the RNA preparations.
3.5 qPCR analysis of gene expression
The qPCR assays of gene expression were performed on
twelve RNA samples that included three samples of sham
control RNA plus three samples each of RNA from tissues
implanted with 13-93B3Cu glass beads for one, two, and
three weeks. The results obtained are presented in Table 3
as ∆Ct values and as 2^(−∆∆Ct) values. The ∆Ct values
represent expression of the FGF-2 and VEGF target genes
normalized to the GAPDH endogenous control gene in the
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sham and bead implanted tissues. The statistical analy-
ses of the ∆Ct mean values revealed a marginally signifi-
cant difference at the p < 0.10 level (p = 0.057) between
the levels of VEGF gene expression in tissues implanted
with 13-93B3Cu glass beads for three weeks and the sham
control tissues. There were no differences, however, be-
tween the levels of FGF-2 gene expression in the glass bead-
implanted tissues and the sham control tissues. The last
2^(−∆∆Ct) value listed in Table 3 indicates the level of
VEGF expression was approximately 1.8 fold higher in tis-
sue with 13-93B3Cu glass beads for three weeks compared
with the level of VEGF expression in the sham control tis-
sues.
4 Discussion
The common procedures and materials currently used for
wound treatment often yield poor outcomes with chronic
skin wounds, a major health care challenge. In that sense,
the positive outcome of a recent clinical study at Phelps
County Regional Medical Center (PCRMC) in Missouri is a
noteworthy exception. This new procedure involved treat-
ment of venous stasis wounds with dressings composed
of borate-based glass microfibers [24]. The results of the
PCRMC clinical trial revealed a dramatic improvement
in the healing of previously non-responsive wounds for
most of the volunteers enrolled in the study. Although
these results were very encouraging, the mode of action of
borate-based glass microfiber in wound healing was not
addressed. Two separate follow-up investigations with rat
models provided compelling evidence of an angiogenic ef-
fect of bioactive borate-based glass materials [23, 25].
This project was undertaken with the hairless mouse
to specifically address the physiological and molecular
mechanisms of the angiogenic effect of borate-based glass
materials. The trans-illuminated skin window prepara-
tions were used with the anticipation they would allow
clear delineation of microvessels. However, the high level
of resolution needed for quantitative histomorphometry
was not uniformly attained. But, the skin window imaging
did allow a consistent qualitative distinction between the
soft tissue responses to borate-based and silicate-based
glass beads. As described in the Results section, much of
the live soft tissue response observed around the borate-
based beads involved the formation of a halo-like body. In
the images with sufficiently high resolution, the halo bod-
ies were recognized to be tissue clusters infused with mi-
crovessels. The formation of microvessel clusters or halo
bodies observed around the 13-93B3 and 13-93B3Cu beads
is also consistent with the granulation tissue repeatedly
observed in the PCRMC clinical study [24].
The conclusion that the halo observed around
borate-based implants in skin window preparations was
microvessel-rich soft tissue is supported by the subdermis
necropsy images obtained in the ancillary experiment. In
those necropsy images, very clearly delineated microves-
sels were visible within the reddishmass observed around
the implanted borate-based glass beads. The reddishmass
encircling the borate-based glass beads in the necropsy
samples was also of similar diameter as the halo bodies
observed in live imaging with skin window preparations.
In addition, the halo body appeared most prominently
around 13-93B3Cu glass bead and was virtually absent
with the silicate-based 13-93 glass beads. The necropsy
samples also showedmicrovessels ‘budding’ toward some
of the 13-93B3Cu glass bead, an indication of angiogenesis.
The histological evaluation of the PAS-stained tissue
sections also supported the interpretation that the halo
bodies surrounding the borate glass beads were tissue
clusters infused with microvessels. The microvessel den-
sities observed in the stained histological sections were
found to be higher within about a millimeter of the im-
planted borate bead compared to areas more distal to the
bead. This finding also agrees with the higher microvessel
densities observed within about a millimeter of subcuta-
neously implanted 13-93B3Cuglassmicrofibers as reported
in the study by Lin and colleagues [25]. A recent study by
Zhao and colleagues also reported evidence of prominent
microvessel growth in full thickness skin defects in ro-
dents treated with 13-93B3Cu glass microfibers [32]. It may
be noted that the bioactive borate glass used in the latter
study contained 3.0 wt% CuO compared to 0.4 wt% CuO in
the 13-93B3Cu glass used in this investigation.
The histomorphometry results revealed higher mi-
crovessel densities around the microfibrous plug than
the fused glass bead. This difference may in part be at-
tributable to the difference in the surface area of the two
physical forms of the glass implants. The borate glass mi-
crofiber plugs have a much higher surface area than the
2 mm diameter glass beads. The borate glass microfibers
with nominal diameters of approximately 2–5 µm have
been shown to undergo complete reaction in three weeks
releasing all of their boron and copper content [21]. The
glass bead appeared to have no reacted surface layer,
an indication of much slower dissolution. The glass mi-
crofiber plugs also had high porosity, another factor that
would contribute to fast dissolution resulting in elevated
localized concentrations of the angiogenic ions borate and
copper [6, 33–35].
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The microvessel densities observed in this study in
response to implantation of the borate glass plugs and
beads were about 30% less than the microvessel den-
sity values reported in the previous study by Lin and
colleagues [25]. This difference may in part reflect differ-
ences in the method of random selection of areas in the
stained slides for enumeration of microvessel densities.
The method used in the previous study [25] involved un-
biased selection of four areas that were all within ap-
proximately one millimeter from the implant site. The
method used in this project involved randomly selecting
four fields from a grid overlay on the entire tissue section
which included areas that were a fewmillimeters from the
implant site. The calculated average microvessel density
value would be lessened by inclusion of areas for enumer-
ation somewhat distal to the implant.
The effects of borate-based bioactive glass on expres-
sion of vascular endothelial growth factor (VEGF) in vivo
had not been investigated prior to this study. Thus, an im-
portant andnovel aspect of this investigation is the finding
that skin tissue implanted with a 13-93B3Cu glass bead for
threeweeks exhibited elevated expression of VEGFmRNA,
potentially triggering elevated VEGF, a growth factor with
an essential role in wound healing [36]. Fibroblast growth
factor-2 (FGF-2) has also been reported to be important in
vasculogenesis [37]. However, the results of this study did
not indicate increased expression of FGF-2 mRNA in re-
sponse to the 13-93B3Cu glass beads. The relativelymodest
1.8-fold increase in VEGF expression after three weeks in
response to the 13-93B3Cu beadsmay be related to the slow
dissolution of the glass beads. Higher levels of VEGF ex-
pression might be anticipated in response to implantation
of more rapidly dissolving 13-93B3Cu glass microfibers.
The results of this project provide additional evidence
that the borate-based bioactive glass beads andmicrofiber
plugs promote angiogenesis, an essential step in wound
healing. In addition, these positive results provide evi-
dence that these materials are potentially useful for treat-
ing chronic non-healing wounds. An important outcome
was the finding that copper-doped 13-93B3Cu glass is able
to stimulate VEGF expression, thereby potentially trigger-
ing an angiogenic response. Collectively, these findings
suggest bioactive borate glass would be a simple but ef-
fective vehicle for delivery of pro-angiogenic ions as an
alternative to expensive growth factors for treatment for
chronicwounds. Additionalwork is needed to determine if
13-93B3Cu glass microfibers would, by virtue of their high
surface area, be more effective than the 13-93B3Cu glass
beads in triggering expression of VEGF as well as other an-
giogenic cytokines in soft tissues.
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